Who Can Participate?
Age Range
18-110
Looking for Healthy Participants
No
What is Involved?
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
[223675] A Phase1b/2, multicenter, randomized, open-label study to evaluate the efficacy and safety of GSK5764227 alone and in combination in participants with previously treated advanced unresectable or metastatic gastrointestinal solid tumors
Principal Investigator
Nicholas
DeVito
Protocol Number
PRO00118141
NCT ID
NCT06885034
Phase
I/II
Enrollment Status
Open to Enrollment